Abstract
Treatment of IgE-mediated food allergy with standard protein-based allergen immunotherapy has proven both unsuccessful and hazardous. Allergen gene vaccination represents a promising alternative, but low efficiency in immunization represent a major limitation for efficient gene vaccination. The current study is to explore the prophylactic and therapeutic efficacy of poly-l-lysine (PLL) modified peanut DNA vaccine on peanut protein induced allergy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
